세계의 4D 바이오프린팅 시장 보고서(2025년)
4D Bioprinting Global Market Report 2025
상품코드 : 1680797
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 200 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

4D 바이오프린팅 시장 규모는 향후 몇 년 동안 비약적인 성장을 보일 것으로 예상되며, 2029년에는 29.9%의 CAGR로 3,400만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 장기 이식 수요 증가, 고령화 인구 증가, 만성질환 유병률 증가, 의료 지출 증가, 맞춤형 의료에 대한 수요 증가에 기인합니다. 예측 기간의 주요 동향으로는 기술 발전, 산학협력, 인공지능의 통합, 분산형 제조로의 전환, 3D 이미징 기술과의 통합 등을 들 수 있습니다.

장기 이식에 대한 수요 증가는 향후 몇 년 동안 4D 바이오프린팅 시장의 성장을 견인할 것으로 예상됩니다. 장기 이식은 장기 부전이나 기능 장애로 인해 장기나 조직이 필요한 개인(기증자)에서 다른 개인(수혜자)에게 외과적으로 이식하는 것을 말합니다. 이러한 수요는 장기 부전이나 기능 장애를 앓고 있는 사람들의 생명을 구하고 삶의 질을 향상시켜야 한다는 매우 중요한 필요성에서 비롯된 것으로, 4D 바이오프린팅은 재생의학을 발전시켜 장기 이식을 지원하고, 기능적 능력을 갖춘 복잡한 조직과 장기를 정밀하게 제작함으로써 기증자 장기 부족에 대한 잠재적 해결책을 제공하고 이식 성공률을 향상시킬 수 있습니다. 예를 들어, 2024년 1월 미국 정부 기관인 장기 조달 및 이식 네트워크(OPTN)의 데이터에 따르면, 2023년에 생체 및 사망한 기증자를 통해 46,632건의 장기 이식이 완료되었습니다. 이는 2022년 대비 8.7%, 2021년 대비 12.7% 증가한 수치입니다. 이처럼 장기 이식에 대한 수요 증가로 인해 4D 바이오프린팅 시장 확대에 박차를 가하고 있습니다.

맞춤형 의료의 부상으로 인해 향후 몇 년 동안 4D 바이오프린팅 시장의 성장이 가속화될 것으로 예상됩니다. 맞춤형 의료는 환자 개개인의 특성에 따라 의료 결정, 개입 및 치료를 맞춤화하는 맞춤형 의료 접근 방식을 채택하고 있으며, 4D 바이오프린팅은 다양한 환경 자극에 적응할 수 있는 지능적이고 환경 반응성이 높은 생물학적 구조, 조직 및 장기의 제조를 촉진함으로써 맞춤형 의료에서 중요한 역할을 하고 있습니다. 주목할 만한 것은 미국에 기반을 둔 전문 기관인 Personalized Medicine Coalition의 2022년 데이터에 따르면, 맞춤형 의료의 승인이 크게 증가하여 전체 승인된 치료법의 약 34%를 차지할 것으로 나타났다는 점입니다. 이는 맞춤형 의료 솔루션에 대한 수요 증가와 이에 따른 4D 바이오프린팅 시장의 성장 궤도에 힘을 실어줄 것으로 보입니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

4D bioprinting represents an advanced manufacturing technique that combines 3D bioprinting with dynamic functionalities, enabling the creation of biomimetic structures capable of adapting shape or function over time in response to external stimuli. This technology facilitates the fabrication of tissues and structures that can emulate the dynamic functionalities of natural tissues.

The primary technologies utilized in 4D bioprinting include extrusion-based, laser-based, inkjet-based, and other methodologies. Extrusion-based technology involves selectively dispensing material through a nozzle or orifice to build a three-dimensional object, serving various applications including biomedical uses. These applications are employed by pharmaceutical and biotechnology companies, academic research and development institutions, among others.

The 4D bioprinting market research report is one of a series of new reports from The Business Research Company that provides 4D bioprinting market statistics, including 4D bioprinting industry global market size, regional shares, competitors with a 4D bioprinting market share, detailed 4D bioprinting market segments, market trends and opportunities, and any further data you may need to thrive in the 4D bioprinting industry. This 4D bioprinting market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The 4D bioprinting market size has grown exponentially in recent years. It will grow from $0.09 billion in 2024 to $0.12 billion in 2025 at a compound annual growth rate (CAGR) of 30.2%. The growth in the historic period can be attributed to rise in geriatric population, increasing healthcare expenditure, rise in 3D bioprinting startups, increasing investments in R&D, growing prevalence of chronic diseases.

The 4D bioprinting market size is expected to see exponential growth in the next few years. It will grow to $0.34 billion in 2029 at a compound annual growth rate (CAGR) of 29.9%. The growth in the forecast period can be attributed to increasing demand for organ transplant, rising aging population, increasing prevalence of chronic diseases, increasing healthcare expenditure, rising demand for personalized medicine. Major trends in the forecast period include technological advancements, collaborations between academia and industry, integration of artificial intelligence, shift towards decentralized manufacturing, integration with 3D imaging technologies.

The rising demand for organ transplants is anticipated to drive the growth of the 4D bioprinting market in the coming years. Organ transplants involve surgically transferring an organ or tissue from one individual (the donor) to another (the recipient) who requires it due to organ failure or dysfunction. This demand stems from the vital need to save lives and enhance the quality of life for those affected by organ failure or dysfunction. 4D bioprinting supports organ transplants by advancing regenerative medicine, precisely fabricating complex tissues and organs with functional capabilities, which provides a potential solution to the donor organ shortage and improves transplant success. For example, in January 2024, data from the Organ Procurement and Transplantation Network (OPTN), a U.S.-based government organization, showed that 46,632 organ transplants were completed in 2023 using both living and deceased donors. This reflects an 8.7% increase compared to 2022 and a 12.7% rise from 2021. Thus, the growing demand for organ transplants is fueling the expansion of the 4D bioprinting market.

The rising prominence of personalized medicine is anticipated to drive the expansion of the 4D bioprinting market in the forthcoming years. Personalized medicine adopts a tailored medical approach that customizes healthcare decisions, interventions, and treatments according to individual patient characteristics. 4D bioprinting assumes a critical role in personalized medicine by facilitating the fabrication of intelligent, environmentally responsive biological structures, tissues, and organs capable of adapting to diverse environmental stimuli. Notably, in 2022, data from the Personalized Medicine Coalition, a US-based professional organization, highlighted a significant increase in the approval of personalized medicines, accounting for approximately 34% of all newly approved therapies. This marks a substantial uptick from previous years, underscoring the growing demand for personalized medical solutions and subsequently driving the growth trajectory of the 4D bioprinting market.

Leading companies in the 4D bioprinting market are establishing strategic partnerships to boost their technological capabilities and speed up the development of innovative solutions in tissue engineering and regenerative medicine. These collaborations also aim to drive innovation and broaden research and development initiatives. For example, in March 2024, Poietis, a France-based biotechnology company specializing in 4D laser bioprinting, partnered with HVD Life Science. Through this partnership, Poietis seeks to promote its Next Generation Bioprinting (NGB-R) platform in Germany and enhance access to advanced bioprinting technology for researchers in tissue engineering, regenerative medicine, and drug discovery. HVD Life Science, an Austria-based company, focuses on the marketing and distribution of life science solutions.

Major companies operating in the 4D bioprinting market are 3D Systems Corporation, CELLINK AB, EnvisionTEC Inc., Advanced Solutions Life Sciences, Nanoscribe, Aspect Biosystems Ltd., Aleph Farms, BioBots Inc., Sculpteo, Prellis Biologics, Rokit Healthcare, Cyfuse Biomedical, 3D Bioprinting Solutions, 4D Biomaterials Ltd., Allevi Inc., Cellenion, FluidForm, Methuselah Health, Nanofabrica, OxSyBio Ltd., Poietis S.A.S., REGEMAT 3D S.L., Replicel Life Sciences Inc., VIVAX BIO, Organovo Holdings Inc.

North America was the largest region in the 4D bioprinting market in 2024. The regions covered in the 4d bioprinting market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the 4d bioprinting market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The 4D bioprinting market consists of revenues earned by entities providing services such as consulting, design, and customization of 4D bio printed products.The market value includes the value of related goods sold by the service provider or included within the service offering. The 4D bioprinting market also includes sales of 4D bioprinters and related consumables such as bioinks and biomaterials. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

4D Bioprinting Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on 4d bioprinting market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for 4d bioprinting ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The 4d bioprinting market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. 4D Bioprinting Market Characteristics

3. 4D Bioprinting Market Trends And Strategies

4. 4D Bioprinting Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global 4D Bioprinting Growth Analysis And Strategic Analysis Framework

6. 4D Bioprinting Market Segmentation

7. 4D Bioprinting Market Regional And Country Analysis

8. Asia-Pacific 4D Bioprinting Market

9. China 4D Bioprinting Market

10. India 4D Bioprinting Market

11. Japan 4D Bioprinting Market

12. Australia 4D Bioprinting Market

13. Indonesia 4D Bioprinting Market

14. South Korea 4D Bioprinting Market

15. Western Europe 4D Bioprinting Market

16. UK 4D Bioprinting Market

17. Germany 4D Bioprinting Market

18. France 4D Bioprinting Market

19. Italy 4D Bioprinting Market

20. Spain 4D Bioprinting Market

21. Eastern Europe 4D Bioprinting Market

22. Russia 4D Bioprinting Market

23. North America 4D Bioprinting Market

24. USA 4D Bioprinting Market

25. Canada 4D Bioprinting Market

26. South America 4D Bioprinting Market

27. Brazil 4D Bioprinting Market

28. Middle East 4D Bioprinting Market

29. Africa 4D Bioprinting Market

30. 4D Bioprinting Market Competitive Landscape And Company Profiles

31. 4D Bioprinting Market Other Major And Innovative Companies

32. Global 4D Bioprinting Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The 4D Bioprinting Market

34. Recent Developments In The 4D Bioprinting Market

35. 4D Bioprinting Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기